WORTZMAN MARILYN E 4
4 · Transcept Pharmaceuticals Inc · Filed Jun 15, 2011
Insider Transaction Report
Form 4
WORTZMAN MARILYN E
VP, Finance
Transactions
- Exercise/Conversion
Common Stock
2011-06-15$1.77/sh+4,000$7,075→ 4,217 total - Exercise/Conversion
Employee Stock Option (right to buy)
2011-06-15−4,000→ 8,027 totalExercise: $1.77Exp: 2017-04-04→ Common Stock (4,000 underlying) - Sale
Common Stock
2011-06-15$10.11/sh−4,000$40,444→ 217 total
Footnotes (3)
- [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on August 13, 2010.
- [F2]The sale price reported in column 4 of Table 1 represents the weighted average sales price of the shares sold ranging from $10.07 to $10.15 per share. Upon request of the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
- [F3]One-fourth of the shares subject to the option vested on March 16, 2008 and one forty-eighth of the shares shall vest monthly thereafter.